3

PRIMARY DOCUMENT

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: August 31, 2022
Period of Report: March 19, 2020
Accession Number: 0001096906-22-002067

View Document ↗ View on SEC.gov ↗